...
首页> 外文期刊>Medical science monitor : >Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
【24h】

Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.

机译:印度原产利什曼原虫的78kDa蛋白的血清诊断和免疫预防潜力。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: The serodiagnosis of visceral leishmaniasis due to Leishmaniadonovani using crude parasite antigen is complicated in many endemic areas by cross-reactions with serumfrom humans infected with other protozoan diseases. The search for pure antigens avoiding such cross-reactionsis in progress. Developing a vaccine against cutaneous leishmaniasis has been much more successful thanagainst visceral leishmaniasis. Immunoprophylactic studies using various combinations of antigens andadjuvants are also in progress, and several strategies are in use, with varying degrees of success. MATERIAL/METHODS:Promastigotes of Leishmania donovani were used. The 78kDa protein was purified by a monoclonal antibodytagged CNBr sepharose CL-4B column. The presence of the protein in both stages of the parasite and inkala-azar patient serum was analyzed by western blotting. ELISA was used for serodiagnosis and isotypeanalysis of antibodies produced in immunized mice. Immunoprophylactic studies were carried out basedon in vitro transformation of amastigotes to promastigotes. RESULTS: The 78 kDa membrane protein, presentin both amastigote and promastigote forms of the parasite, was purified to homogeneity. The protein wasfound to have serodiagnostic potential to detect kala-azar. BALB/c mice immunized with 78kDa proteinrevealed reduction in spleen parasitemia. Isotype profiles of antibodies produced by immunized mice showedincreased production of IgG2a and decreased IgG1 levels. CONCLUSIONS: Our results demonstrated, for thefirst time, the serodiagnostic and immunoprophylactic use of a pure membrane protein isolated from Leishmaniadonovani of Indian origin.
机译:背景:在许多流行地区,由于与感染其他原生动物疾病的人的血清发生交叉反应,利什曼原虫通过粗寄生虫抗原引起的内脏利什曼病的血清学诊断非常复杂。寻找避免这种交叉反应的纯抗原正在进行中。研发针对皮肤利什曼病的疫苗比对抗内脏利什曼病更成功。使用抗原和佐剂的各种组合的免疫预防研究也在进行中,并且使用了几种策略,并取得了不同程度的成功。材料/方法:使用了利什曼原虫的前鞭毛体。用单克隆抗体标记的CNBr琼脂糖CL-4B柱纯化78kDa蛋白。通过蛋白质印迹分析了寄生虫和inkala-azar患者血清的两个阶段中蛋白质的存在。 ELISA用于免疫小鼠中产生的抗体的血清诊断和同种型分析。免疫预防性研究是基于将变形虫转化为前鞭毛虫的体外研究。结果:纯化的78 kDa膜蛋白,既存在于鞭毛体也存在于前鞭毛体中,被纯化至同质。发现该蛋白质具有检测黑素病的血清诊断潜力。用78kDa蛋白免疫的BALB / c小鼠揭示了脾寄生虫病的减少。免疫小鼠产生的抗体的同种型谱显示IgG2a产生增加而IgG1水平降低。结论:我们的研究结果首次证明了从印度利什曼原虫的分离得到的纯膜蛋白的血清学诊断和免疫预防作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号